Fang K C, Raymond W W, Lazarus S C, Caughey G H
Cardiovascular Research Institute, University of California, San Francisco, 94143-0911, USA.
J Clin Invest. 1996 Apr 1;97(7):1589-96. doi: 10.1172/JCI118583.
Gelatinolytic metalloproteinases implicated in connective tissue remodeling and tumor invasion are secreted from several types of cells in the form of inactive zymogens. In this report, characterization of gelatinase activity secreted by the BR line of dog mastocytoma cells reveals a phorbol-inducible, approximately 92-kD, Ca2+ - and Zn2+ -dependent proenzyme cleaved over time to smaller, active forms. Incubation of cells with the general serine protease inhibitor, PMSF, prevented proenzyme cleavage and permitted its purification free of activation products. The NH2-terminal 13 amino acids of the purified mastocytoma progelatinase are 50-67% identical to those of human, mouse, and rabbit 92-kD progelatinase (gelatinase B; matrix metalloproteinase-9). Degranulation of mastocytoma cells using ionophore A23187 greatly accelerated proenzyme cleavage, suggesting that a serine protease present in secretory granules hydrolyzed the progelatinase to active fragments. To identify the activating protease, cells were coincubated with ionophore and a panel of selective serine protease inhibitors. Soybean trypsin inhibitor and succinyl-L-Ala-Ala-Pro-Phe-chloromethylketone, which inhibit mast cell chymase, prevented progelatinase activation. Inhibitors of tryptase and dog mast cell protease (dMCP)-3, i.e., aprotinin or bis(5-amidino-2-benzimidazolyl) methane (BABIM), did not. In further experiments using highly purified enzymes, mastocytoma cell chymase activated 92-kD progelatinase in the absence of other enzymes or cofactors; tryptase and dMCP-3, however, had no effect. These data demonstrate that dog mastocytoma cells secrete a metalloproteinase related to progelatinase B that is directly activated outside of the cell by exocytosed chymase, and provide the first demonstration of a cell that activates a matrix metalloproteinase it secretes by cosecreting an activating enzyme. In mastocytomas, this pathway may facilitate tumor invasion of surrounding tissues, and in normal mast cells, it could play a role in tissue remodeling and repair.
参与结缔组织重塑和肿瘤侵袭的明胶分解性金属蛋白酶以无活性酶原的形式从几种细胞类型中分泌出来。在本报告中,对犬肥大细胞瘤细胞BR系分泌的明胶酶活性的表征揭示了一种佛波醇诱导的、约92-kD、依赖Ca2+和Zn2+的酶原,随着时间的推移可裂解为较小的活性形式。用通用丝氨酸蛋白酶抑制剂PMSF孵育细胞可防止酶原裂解,并使其能够在无激活产物的情况下纯化。纯化的肥大细胞瘤前明胶酶的NH2末端13个氨基酸与人类、小鼠和兔子的92-kD前明胶酶(明胶酶B;基质金属蛋白酶-9)具有50-67%的同一性。使用离子载体A23187使肥大细胞瘤细胞脱颗粒大大加速了酶原裂解,这表明分泌颗粒中存在的一种丝氨酸蛋白酶将前明胶酶水解为活性片段。为了鉴定激活蛋白酶,将细胞与离子载体和一组选择性丝氨酸蛋白酶抑制剂共同孵育。抑制肥大细胞糜酶的大豆胰蛋白酶抑制剂和琥珀酰-L-丙氨酸-丙氨酸-脯氨酸-苯丙氨酸氯甲基酮可防止前明胶酶激活。类胰蛋白酶和犬肥大细胞蛋白酶(dMCP)-3的抑制剂,即抑肽酶或双(5-脒基-2-苯并咪唑基)甲烷(BABIM)则不能。在使用高度纯化酶的进一步实验中,肥大细胞瘤细胞糜酶在没有其他酶或辅因子的情况下激活了92-kD前明胶酶;然而,类胰蛋白酶和dMCP-3没有作用。这些数据表明,犬肥大细胞瘤细胞分泌一种与前明胶酶B相关的金属蛋白酶,该酶在细胞外被胞吐的糜酶直接激活,并首次证明了一种细胞通过共分泌激活酶来激活其分泌的基质金属蛋白酶。在肥大细胞瘤中,该途径可能促进肿瘤对周围组织的侵袭,而在正常肥大细胞中,它可能在组织重塑和修复中发挥作用。